BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32308129)

  • 1.
    Puangpetch A; Tiyasirichokchai R; Pakakasama S; Wiwattanakul S; Anurathapan U; Hongeng S; Sukasem C
    Pharmacogenomics; 2020 Apr; 21(6):403-410. PubMed ID: 32308129
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of
    Nguyen ML; Hoang AV; Duong BT; Phung NTN
    HGG Adv; 2023 Apr; 4(2):100183. PubMed ID: 36873097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
    Zhou H; Li L; Yang P; Yang L; Zheng JE; Zhou Y; Han Y
    BMC Cancer; 2018 May; 18(1):516. PubMed ID: 29720126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of NUDT15 on incidence of neutropenia in children with acute lymphoblastic leukemia.
    Buaboonnam J; Sripatanatadasakul P; Treesucon A; Glomglao W; Siraprapapat P; Narkbunnam N; Vathana N; Takpradit C; Phuakpet K; Pongtanakul B; Tongsai S; Sinlapamongkolkul P; Sanpakit K
    Pediatr Int; 2019 Aug; 61(8):754-758. PubMed ID: 31166660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe 6-mercaptopurine-induced hematotoxicity in childhood an ALL patient with homozygous NUDT15 missence variants].
    Kimura S; Hasegawa D; Yoshimoto Y; Hirabayashi S; Hosoya Y; Yoshihara H; Kumamoto T; Tanaka Y; Manabe A
    Rinsho Ketsueki; 2016 Jun; 57(6):748-53. PubMed ID: 27384855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.
    Wahlund M; Nilsson A; Kahlin AZ; Broliden K; Myrberg IH; Appell ML; Berggren A
    J Pediatr; 2020 Jan; 216():150-157.e1. PubMed ID: 31635813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia.
    Khera S; Trehan A; Bhatia P; Singh M; Bansal D; Varma N
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):341-348. PubMed ID: 30474703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of NUDT15 variants by targeted sequencing can identify compound heterozygosity in pediatric acute lymphoblastic leukemia patients.
    Yu CH; Chang YH; Wang DS; Jou ST; Lin CY; Lin KH; Lu MY; Raghav L; Chang HH; Wu KH; Chou SW; Ni YL; Lin DT; Lin SW; Chen HY; Yang YL
    Sci Rep; 2020 Sep; 10(1):14400. PubMed ID: 32873882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia.
    Chikondowa P; Munkombwe D; Chikwambi Z; Kuona P; Masimirembwa C
    Pharmacogenomics; 2023 Jun; 24(8):449-457. PubMed ID: 37248698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood acute lymphoblastic leukemia mercaptopurine intolerance is associated with NUDT15 variants.
    Wang DS; Yu CH; Lin CY; Chang YH; Lin KH; Lin DT; Jou ST; Lu MY; Chang HH; Lin SW; Chen HY; Yang YL
    Pediatr Res; 2021 Jan; 89(1):217-222. PubMed ID: 32221476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.
    Yang JJ; Landier W; Yang W; Liu C; Hageman L; Cheng C; Pei D; Chen Y; Crews KR; Kornegay N; Wong FL; Evans WE; Pui CH; Bhatia S; Relling MV
    J Clin Oncol; 2015 Apr; 33(11):1235-42. PubMed ID: 25624441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of
    Nghia H; Than HH; Dong CV; Oanh TTK; Truc VTT; Ngan CTT; Ngon HT; Binh NT; Dung PC; Anh Vu H; Xinh PT
    Pediatr Hematol Oncol; 2022 Sep; 39(6):561-570. PubMed ID: 35156873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.
    Zgheib NK; Akika R; Mahfouz R; Aridi CA; Ghanem KM; Saab R; Abboud MR; Tarek N; El Solh H; Muwakkit SA
    Pediatr Blood Cancer; 2017 Jan; 64(1):146-150. PubMed ID: 27577869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia.
    Liang DC; Yang CP; Liu HC; Jaing TH; Chen SH; Hung IJ; Yeh TC; Lin TH; Lai CL; Lai CY; Shih LY
    Pharmacogenomics J; 2016 Nov; 16(6):536-539. PubMed ID: 26503813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility to 6-mercaptopurine toxicity related with NUDT15 and ABCC4 variants in Japanese childhood acute lymphoblastic leukemia].
    Tanaka Y
    Rinsho Ketsueki; 2017; 58(8):950-956. PubMed ID: 28883280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia.
    Tanaka Y; Nakadate H; Kondoh K; Nakamura K; Koh K; Manabe A
    Pharmacogenomics J; 2018 Apr; 18(2):275-280. PubMed ID: 28418010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia.
    Moriyama T; Yang W; Smith C; Pui CH; Evans WE; Relling MV; Bhatia S; Yang JJ
    Pharmacogenet Genomics; 2022 Feb; 32(2):60-66. PubMed ID: 34412101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel variants in
    Moriyama T; Yang YL; Nishii R; Ariffin H; Liu C; Lin TN; Yang W; Lin DT; Yu CH; Kham S; Pui CH; Evans WE; Jeha S; Relling MV; Yeoh AE; Yang JJ
    Blood; 2017 Sep; 130(10):1209-1212. PubMed ID: 28659275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations.
    Maillard M; Nishii R; Yang W; Hoshitsuki K; Chepyala D; Lee SHR; Nguyen JQ; Relling MV; Crews KR; Leggas M; Singh M; Suang JLY; Yeoh AEJ; Jeha S; Inaba H; Pui CH; Karol SE; Trehan A; Bhatia P; Antillon Klussmann FG; Bhojwani D; Haidar CE; Yang JJ
    J Natl Cancer Inst; 2024 May; 116(5):702-710. PubMed ID: 38230823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of
    Du S; Huang X; He X; Mao M; Chen M; Zhang R; Shao H; Lv Z; Liu X; Chuan J
    Haematologica; 2024 Apr; 109(4):1053-1068. PubMed ID: 37794799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.